Chapel Allerton Hospital

Leeds LS7 4SA

3 studies enrolling now · 14 studies all time

What they study most

Ankylosing Spondyloarthritis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, Psoriatic, Diffuse Cutaneous Systemic Sclerosis, Huntington Disease, Interstitial Lung Disease, Interstitial Lung Diseases, Microscopic Polyangiitis, Prurigo Nodularis, Psoriatic Arthritis, Scleroderma, Scleroderma, Systemic

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — Running, not enrolling
• GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus — Running, not enrolling
• A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms — Completed
• Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease — Stopped early
• Rituximab Vasculitis Maintenance Study — Completed
• Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) — Withdrawn before enrolling
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed